By G HossainPosted on February 12, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Moderna’s mRNA-1010 was expected to contribute $1 billion to the company’s coffers by 2028. That plan is now out the window after the FDA refused to even look at the application. Flu Vaccine Rejection Imperils Moderna’s Breakeven Plans Post navigation Seres Will Cut 30% of Staff While Shifting Focus to Emerging ProgramsICON shares plunge after launching accounting probe